home / stock / srdx / srdx news


SRDX News and Press, Surmodics Inc.

Stock Information

Company Name: Surmodics Inc.
Stock Symbol: SRDX
Market: NASDAQ
Website: surmodics.com

Menu

SRDX SRDX Quote SRDX Short SRDX News SRDX Articles SRDX Message Board
Get SRDX Alerts

News, Short Squeeze, Breakout and More Instantly...

SRDX - Surmodics secures thrombectomy products agreement with Premier

2024-06-10 08:08:34 ET More on Surmodics Surmodics jumps 18% on acquisition by GTCR Surmodics beats top-line and bottom-line estimates; updates FY24 outlook Seeking Alpha’s Quant Rating on Surmodics Historical earnings data for Surmodics Read...

SRDX - Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.

Access to Premier’s healthcare group purchasing organization (GPO) expected to expand national market reach for Surmodics endovascular thrombectomy solutions. Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announce...

SRDX - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRCL, AMBC, SGRP, SRDX

NEW YORK, NY / ACCESSWIRE / June 5, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Stericycle, Inc. (NASDAQ:SRCL)'s sale...

SRDX - US Companies Moving the Markets, Evening edition
Wed, May 29, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 37.2% to $0.0494 on volume of 615,002,672 shares Innovative Eyewear Inc. (LUCY) rose 131.5% to $0.949 on volume of 566,381,896 shares Faraday Future Intelligent Electric Inc. (FFIE) fell...

SRDX - Hold Recommendation Issued On SRDX By Lake Street

2024-05-29 15:15:03 ET Lake Street analyst issues HOLD recommendation for SRDX on May 29, 2024 01:37PM ET. SRDX was trading at $42.07 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommendati...

SRDX - SRDX Price Target Alert: $43.00. Issued by Lake Street

2024-05-29 15:00:09 ET Brooks O'Neil from Lake Street issued a price target of $43.00 for SRDX on 2024-05-29 13:37:00. The adjusted price target was set to $43.00. At the time of the announcement, SRDX was trading at $42.07. The overall price target consensus is at $36.0...

SRDX - SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR

MONSEY, N.Y., May 29, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $43.00 per share in cash for which Surmodics, Inc. (Nasdaq: SRDX) (“Surmodics”) has agreed to be sold to GTCR, a leading private equity firm. The sale...

SRDX - US Companies Moving the Markets, Morning edition
Wed, May 29, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States ReShape Lifesciences Inc. (RSLS) rose 89.7% to $0.3942 on volume of 109,324,190 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 30.3% to $0.8151 on volume of 100,649,842 shares Innovative Eyewear Inc. (LUCY) rose 61.0% to ...

SRDX - Surmodics jumps 18% on acquisition by GTCR

2024-05-29 07:31:31 ET SRDX stock price gained 18.4% More on Surmodics Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript Surmodics beats top-line and bottom-line estimates; updates FY24 outlook Needham sees BSX, CNMD, RMD beating Street, despite medtech...

SRDX - Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million

Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered into a definitive agreement to be acquired by GTCR, a leading private equity firm with a long track record of investment expertise acro...

Next 10